Antigua and Barbuda vs South-East Asia (WHO region): HIV-positive TB patients on ART (antiretroviral therapy)
Antigua and Barbuda
100.0%
in 2022
South-East Asia (WHO region)
94.0%
in 2024
Antigua and Barbuda rank
1st
South-East Asia (WHO region) rank
4th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Antigua and Barbuda
- South-East Asia (WHO region)
How they compare
Antigua and Barbuda currently reports 100.0% against 94.0% in South-East Asia (WHO region), a difference of 6.0%.
That makes Antigua and Barbuda's figure about 1.1 times South-East Asia (WHO region)'s.
Across all 8 years both countries report, Antigua and Barbuda has been ahead every year.
Antigua and Barbuda ranks 1st and South-East Asia (WHO region) ranks 4th of 144 countries.
Antigua and Barbuda has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Antigua and Barbuda | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 18.3% | 81.7% | Antigua and Barbuda |
| 2010s | 100.0% | 67.8% | 32.2% | Antigua and Barbuda |
| 2020s | 100.0% | 94.0% | 6.0% | Antigua and Barbuda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Antigua and Barbuda or South-East Asia (WHO region)?
- Antigua and Barbuda, at 100.0% against 94.0% in South-East Asia (WHO region) as of 2022.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Antigua and Barbuda and South-East Asia (WHO region)?
- 6.0%, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and South-East Asia (WHO region)?
- 8 years are reported by both, from 2005 to 2022.
- How do Antigua and Barbuda and South-East Asia (WHO region) rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Antigua and Barbuda ranks 1st and South-East Asia (WHO region) ranks 4th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.